別品名 |
5-aminoimidazole-4 -carboxamide-1-β-D-ribofuranoside, 5-Amino-1-(β-D-ribofuranosyl)-1H-imidazole-4-carboxamide
|
別包装 |
あり
|
純度 |
>=98%
|
分子量 |
258.23
|
CAS RN® |
2627-69-2
|
化合物の概要 |
AMPK activator.
|
溶媒 |
Soluble in water (9 mg/ml), DMSO or dimethyl formamid
|
参考文献 |
Mukhopadhyay S, Chatterjee A, Kogan D, et al. 5-Aminoimidazole-4-carboxamide-1-β-4-ribofuranoside (AICAR) enhances the efficacy of rapamycin in human cancer cells. Cell Cycle. 2015 Aug 31:0. [Epub ahead of print]. PMID: 26323019.Greig FH, Ewart MA, McNaughton E, et al. The hypotensive effect of acute and chronic AMP-activated protein kinase activation in normal and hyperlipidemic mice. Vascul Pharmacol. 2015 Jul 18. [Epub ahead of print]. PMID: 26196300.Niederberger E, King TS, Russe OQ, et al. Activation of AMPK and its Impact on Exercise Capacity. Sports Med. 2015 Jul 18. [Epub ahead of print]. PMID: 26186961.Radika MK, Anuradha CV. Activation of insulin signaling and energy sensing network by AICAR, an AMPK activator in insulin resistant rat tissues. J Basic Clin Physiol Pharmacol. 2015 Jun 27. [Epub ahead of print]. PMID: 26124049.
|
|
メーカー |
品番 |
包装 |
LKT
|
A3208
|
50 MG
|
※表示価格について
当社在庫 |
なし
|
納期目安 |
1週間程度
|
保存温度 |
-20℃
|
|